Copyright © 2005, European Society of Cardiology
Tyrosine phosphatases in vessel wall signaling
aCancer Center Karolinska, Department Of Oncology and Pathology, R8:03, Karolinska Institutet, 171 76 Stockholm, Sweden
bProcter and Gamble Pharmaceuticals, 8700 Mason Montgomery Road, Box 1064, Mason, OH 45040, USA
cInstitute of Molecular Cell Biology, Medical Faculty, Friedrich Schiller University, D-07747 Jena, Germany
* Corresponding author. Tel.: +46 8 5177 0232; fax: +46 8 33 90 31. Email address: Arne.Ostman{at}cck.ki.se
Protein tyrosine phosphatases (PTPs) are critical regulators of cellular processes like migration, proliferation and differentiation that are involved in physiological and pathological vessel wall function. In this review, we summarize the biochemistry of this enzyme family, discuss the present knowledge concerning the identity and involvement of PTPs in vascular cells and in pathways of relevance to cardiovascular diseases. We also briefly introduce ongoing efforts to develop inhibitors of PTPs, and finally point to some opportunities for use of such agents in novel treatment strategies.
KEYWORDS Protein tyrosine phosphatase; Cardiovascular disease; Cell signaling; Angiogenesis; Antherogenesis
Time for primary review 29 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Tabet, E. L. Schiffrin, G. E. Callera, Y. He, G. Yao, A. Ostman, K. Kappert, N. K. Tonks, and R. M. Touyz Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR Circ. Res., July 18, 2008; 103(2): 149 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kappert, J. Paulsson, J. Sparwel, O. Leppanen, C. Hellberg, A. Ostman, and P. Micke Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation FASEB J, February 1, 2007; 21(2): 523 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kappert, J. Sparwel, A. Sandin, A. Seiler, U. Siebolts, O. Leppanen, S. Rosenkranz, and A. Ostman Antioxidants Relieve Phosphatase Inhibition and Reduce PDGF Signaling in Cultured VSMCs and in Restenosis Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2644 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Post and J. Waltenberger Modulation of growth factor action in the cardiovascular system Cardiovasc Res, February 15, 2005; 65(3): 547 - 549. [Full Text] [PDF]
|
|